Among these peptides, Abeta1–40 and Abeta1–42 have been the dominant focus research, but it is well established that N- and C-terminally truncated or modified forms of Abeta peptides also exist in AD brain and cerebrospinal fluid (CSF). The gene discussed is APP; the disease is Alzheimer disease.